MTE #20: Expanding the Frontiers for Liver Transplantation in Severe Alcohol-Associated Hepatitis (Ticketed)

Nov 17 2024
Convention Center: Room 31 A
7:00 AM - 7:45 AM
Ticketed Event

World Class Speakers

Brian P Lee, MD
Discussion Leader

Brian P Lee, MD

Keck School of Medicine
Anand V Kulkarni, MD, DM
Discussion Leader

Anand V Kulkarni, MD, DM

Asian Institute of Gastroenterology

Description

The faculty for this session explore the latest criteria and considerations for selecting candidates for liver transplantation in the context of severe alcohol-associated hepatitis. Speakers delve into the prognostic factors that influence outcomes and discuss the potential and challenges of living-donor liver transplantation as a treatment option. 
 

Journey Maps

Objectives

  • Identify and describe how to apply the selection criteria for liver transplantation in persons with severe alcohol-associated hepatitis considering the ethical and medical implications.
  • Discuss the prognostic indicators that are critical in predicting outcomes for liver transplantation in the setting severe alcohol-associated hepatitis, and how they aid in better patient selection and management strategies.
  • Describe the role of living-donor liver transplantation in the context of severe alcohol-associated hepatitis, assessing its viability, benefits, and associated risks to optimize patient care and expand treatment options.